EAA and BCAA

What are EAA and BCAA, and what is the difference between them?

The nine essential amino acids (EAA) are histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, and valine; the body obtains them from food because it cannot make them itself. Leucine, isoleucine, and valine are their branched-chain subgroup, the BCAAs. According to NIH ODS, BCAAs make up about 25% of the amino acids in foods with complete protein and 14–18% of human skeletal muscle proteins and, unlike other EAAs, can be used for energy in muscle mitochondria during exercise; leucine in particular is thought to be able to stimulate protein synthesis in exercised muscle. ^[1]

Most complete proteins consist of about 40% EAA; a meal or snack containing 25 g of total protein provides about 10 g of EAA. NIH ODS stresses that “all EAAs are required for muscle protein synthesis”; a product containing only the three BCAAs is therefore not the same as a complete protein or an EAA mixture. ^[1] The ISSN protein position also states that acute protein doses should contain 700–3,000 mg of leucine in addition to a balanced EAA profile and that total daily protein intake in the range of 1.4–2.0 g/kg is sufficient for most people who exercise. ^[4] Together, these two findings show that a BCAA label does not substitute for the total protein amount and meal quality.

Do BCAAs increase muscle protein synthesis?

Wolfe’s 2017 review draws a theoretical limit: the maximum effect of BCAA alone on muscle protein synthesis in the fasted state is the difference between muscle protein breakdown and synthesis (about 30% above synthesis), because the other EAAs needed for new protein can only be supplied from breakdown. The author reports finding no human study measuring the effect of orally ingested BCAA alone, and that in two studies examining intravenously given BCAA, muscle protein synthesis and breakdown decreased together, and concludes that “the claim that BCAA consumption stimulates muscle protein synthesis is unsupported.” According to the article’s conflict-of-interest statement, the author holds shares in an essential amino acid mixture company and has received grants or fees from the food industry. ^[2]

The 2017 study by Jackman and colleagues measured this question directly: 10 resistance-trained men aged 20.1 ± 1.3 years received 5.6 g of BCAA or a placebo drink immediately after exercise in two trials; myofibrillar protein synthesis was 22% higher with BCAA in the 4-hour measurement (0.110 ± 0.009 versus 0.090 ± 0.006 %/hour; p=0.012) and an increase in mTORC1 signaling was seen. According to the full text, the study was supported by a research grant from a consumer health products company. ^[3] This result comes from a small crossover study; it is a measurement of muscle synthesis over a few hours, muscle gain or strength was not measured, and it covers only young, trained men.

So although the two sources appear to conflict, they answer the same question at different scales: one reports the theoretical upper limit and the lack of measurement, the other a short-term measurement. Neither shows that BCAA is a sufficient or superior route to long-term muscle growth.

Are BCAAs superior to protein for muscle gain?

NIH ODS reports that in a few short studies lasting 3–6 weeks, about 10–14 g of BCAA per day may have increased muscle mass and strength gains during training; overall, however, it states that studies provide inconsistent evidence that BCAA stimulates muscle protein synthesis beyond what an adequate amount of high-quality protein can provide. Whether the effect of taking protein and BCAA before or after exercise differs is also unclear. ^[1]

NIH ODS’s conclusion is clear: it has not been consistently shown that BCAAs or their individual components increase exercise performance, build muscle mass, or aid recovery. Animal foods or complementary plant combinations supply all EAAs, and therefore BCAAs, on their own; so do protein powders, especially whey protein, whose leucine content is higher than casein and soy. ^[1]

Do BCAAs improve endurance performance?

No benefit shown. According to NIH ODS, very little evidence to date shows that BCAA supplements improve performance in endurance-related aerobic activities. It has been proposed that BCAAs may delay the sensation of fatigue or maintain focus by competing with tryptophan for entry into the brain, but this effect has not been well studied. ^[1]

Do BCAAs reduce post-exercise muscle soreness?

The 2019 meta-analysis by Fedewa and colleagues pooled 37 effect sizes from 8 studies (2007–2017) comparing BCAA with placebo after exercise. In a total of 61 participants, BCAA reduced post-exercise delayed-onset muscle soreness (DOMS) (ES 0.7286; 95% CI 0.5017–0.9555; p < 0.001). ^[6] The sample is very small and DOMS is a subjective measure.

The 2021 systematic review by Weber and colleagues covered 10 RCTs (9 in the meta-analysis) examining DOMS after muscle damage produced by a single exercise session; in seven studies, BCAA reduced DOMS at 24–72 hours. The authors report that, because of high between-study variability (training status, dose, timing, damage severity), the effect could not be concluded in untrained people, with acute use, and at higher doses; and that it was useful in reducing DOMS at low doses, in trained people, and with mild-to-moderate muscle damage. ^[5] Reduced muscle soreness does not imply a muscle strength or hypertrophy outcome.

Do BCAAs and EAAs work against muscle loss in older adults?

The 2022 meta-analysis by Bai and colleagues covered 35 RCTs examining BCAA-rich supplements in older adults (14 had suspected bias). Compared with placebo or control, SMD was 0.35 (95% CI 0.15–0.55) for muscle strength, 0.25 (0.10–0.40) for muscle mass, and 0.29 (0.00–0.57; p=0.05) for physical performance. In subgroup analysis, EAA supplementation increased handgrip strength more than whey protein; the authors state that the results should be interpreted with caution because of high heterogeneity. ^[7] The subgroup finding is not the main result, and “BCAA-rich” supplements are mixtures.

The 2021 umbrella review by the nutritional interventions working group of the Belgian Society of Geriatrics and Gerontology pooled 15 systematic reviews examining proteins, EAA, leucine, HMB, creatine, and multicomponent supplements for people over 65; because the number of reviews was small and their quality low to moderate, the level of evidence for most recommendations was found to be low to moderate. The best evidence is for leucine, owing to its significant effect on muscle mass in older adults with sarcopenia; protein supplementation added to resistance training is recommended to increase muscle mass and strength, particularly in people with obesity and when used for ≥24 weeks. ^[8]

Are BCAAs used in cirrhosis and hepatic encephalopathy?

This is the best-studied clinical area for BCAA and a context separate from sports supplements. The 2026 Cochrane update covered 18 RCTs comparing BCAA with control in adults with cirrhosis and hepatic encephalopathy (934 adults; 13 with overt and 5 with covert encephalopathy; oral BCAA in 10 and intravenous BCAA in 8). BCAA reduced encephalopathy (RR 0.79; 95% CI 0.64–0.96; low-certainty evidence), and there may have been little or no effect on all-cause death (RR 0.89; CI 0.71–1.12; very low certainty). Nausea and diarrhea occurred in 58 of 477 participants (12%) in the BCAA group and in 16 of 538 participants (3%) in the control (diet) group; the direction of the effect was uncertain (RR 2.05; CI 0.40–10.58; very low certainty). Three studies had intervention support from for-profit organizations. There are no studies in children. ^[9] These results apply to people with liver disease and are treatment decisions requiring physician management; they cannot be adapted to healthy people.

How safe are EAA and BCAA?

According to NIH ODS, BCAA supplementation of up to 20 g per day in divided doses appears safe; for leucine alone, an upper safe intake limit of 500 mg/kg/day (about 38 g/day for a 75 kg man) has been proposed in healthy young and older men. ^[1] The same text states that the Food and Nutrition Board has not set an upper limit (UL) for protein but recommends caution with high protein intake from foods and supplements because data on possible adverse effects are limited; and that high-protein diets of two to three times the RDA of 0.8 g/kg/day for healthy adults do not increase the risk of kidney stones or dehydration, or impair kidney function and bone health, in healthy people. ^[1] These data cover healthy people; no direct data are provided for people with kidney disease.

NIH ODS states that the EAAs needed for muscle protein synthesis are supplied by adequate dietary protein; an amino acid product does not replace this foundation. ^[1] In the Cochrane data, nausea and diarrhea were numerically more common in the BCAA group (12% and 3%), but the direction of the effect is uncertain with very low certainty. ^[9]

EAA and BCAA supplements in Türkiye

Approval from the Ministry of Agriculture and Forestry is mandatory for every food supplement to be placed on the market in Türkiye. ^[10] In the Restricted Substances List (last updated September 21, 2026), L-isoleucine, L-leucine, and L-valine (“together or alone”) are in a single row; the ages 11 and over column shows 3,000 mg/day, the sources are bovine protein hydrolysate and chemical synthesis for L-isoleucine, chemical synthesis and sheep wool for L-leucine, and bovine protein hydrolysate for L-valine; published May 2, 2016. According to the footnote attached to the L-leucine row, if used together with an additive function in the supplement’s composition, the total amount cannot exceed the maximum limit in the list. No values are entered in the ages 4–10 columns. ^[11]

The limits in the ages 11 and over column for the other EAAs are as follows: L-lysine 500 mg/day (250 mg/day for ages 4–10), L-methionine 910 mg/day (at most 800 mg/day when used together with cysteine), L-phenylalanine 500 mg/day, L-tryptophan 500 mg/day, histidine 200 mg/day, and L-threonine 232 mg/day. The list has no separate row for an “essential amino acid mixture”; the sum of these six rows is about 2.84 g, and together with the BCAA row about 5.84 g (an arithmetic sum, not the list’s own statement). ^[11]

These limits are not in the same context as the study scale: in short BCAA studies about 10–14 g per day was used, and the single dose in the Jackman study was 5.6 g of BCAA; both are above the BCAA row’s limit of 3 g/day. That a meal with 25 g of protein provides about 10 g of EAA also exceeds the sum of the six EAA rows and the BCAA row (≈5.84 g). ^{[1] [3] [11]} Study doses cannot be taken as a criterion for a product approved in Türkiye.

Who should be cautious?

• People with cirrhosis and hepatic encephalopathy: BCAA in this group is a physician-managed clinical treatment area; in Cochrane, nausea and diarrhea were seen in 12% of the BCAA group and 3% of controls. ^[9]
• Digestive complaints: Nausea and diarrhea were reported in the Cochrane data; the direction of the effect is uncertain with very low certainty. ^[9]
• Competitive athletes: NIH ODS notes that products marketed for bodybuilding can be adulterated with undeclared steroids and prescription drugs, which can lead to doping sanctions. ^[1]
• Ages 4–10: In the Restricted Substances List, the BCAA row has no value for this age group; separate, lower limits exist, such as 250 mg/day for L-lysine. ^[11]

Evidence table: claim, population, and limits

This guide does not recommend personal doses or treatment; in liver disease, kidney disease, metabolic disease, and regular medication use, the decision depends on individual clinical evaluation.